Market revenue in 2022 | USD 57.9 million |
Market revenue in 2030 | USD 120.5 million |
Growth rate | 9.6% (CAGR from 2022 to 2030) |
Largest segment | Imaging devices |
Fastest growing segment | Monitoring Devices |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Imaging Devices, Monitoring Devices |
Key market players worldwide | Integra LifeSciences, Nihon Kohden Corp, Compumedics-alpha trace, InfraScan, Raumedic AG, Oculogica |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to traumatic brain injuries assessment and management devices market will help companies and investors design strategic landscapes.
Imaging devices was the largest segment with a revenue share of 55.96% in 2022. Horizon Databook has segmented the India traumatic brain injuries assessment and management devices market based on imaging devices, monitoring devices covering the revenue growth of each sub-segment from 2017 to 2030.
Growth of the TBIs assessment and management devices market in India can be attributed to supportive government initiatives and rise in incidence of TBIs, majorly due to road accidents (60%) followed by falls (20%-25%), and violence (10%). According to a WHO Global Report on Road Safety 2018, around 11% of the road accident-associated deaths in the world are reported from India.
Approximately, 4, 67,044 road accidents were reported in the year 2018. This is anticipated to impel market growth over the forecast period. Moreover, the Indian government has introduced favorable policies, such as National Health Policy (NHP), to help improve healthcare outcomes. In order to reduce dependence on import, the government has drafted the National Medical Device Policy to support the “Make in India” initiative. Moreover, a 12.0% Goods and Services Tax (GST) was introduced all over India, with effect from July 2017.
This new GST rate is focused on reducing manufacturing costs, thereby benefitting Indian consumers and local medical equipment manufacturers. Such initiatives are anticipated to boost market demand over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the India traumatic brain injuries assessment and management devices market, including forecasts for subscribers. This country databook contains high-level insights into India traumatic brain injuries assessment and management devices market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account